Dr Sarah Smith, consultant clinical scientist and director of the Scottish Newborn Screening Laboratory on the Queen Elizabeth University Hospital campus in Glasgow, where the tests will be analysed, said that the “important screening evaluation” would “benefit babies and their families across Scotland by allowing babies with this condition to access treatment where it is appropriate more quickly, leading to better outcomes”.
